Patients with 'cancer of unknown primary origin' have metastatic malignant disease without an identifiable primary site. For patients with this condition the type of tumour, the extent of its spread, ...

We will not update the NICE guideline on metastatic malignant disease of unknown primary origin in adults at this time. The impact of evidence on current recommendations will be evaluated as soon as ...

Myeloproliferative neoplasms (MPNs) are still difficult to treat. Researchers have discovered a new therapeutic approach that could fundamentally change this situation. MPNs are a group of rare ...

For example, those with basal cell cancer ... researchers in the most recent study hope that the new data on malignant melanoma and Alzheimer's disease will help them further investigate this ...

While an estimated 14.1 million people in the world are living with cancer, the origins of the devastating disease have remained ... definitive evidence of malignant cancer.